Ho Il Choi

This inventor holds 14 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Peptron, Inc., Lucky Limited, Lg Chemical Ltd.. Active years: 1996-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ho Il Choi. Retrieved from https://idiyas.com/inventor/ho-il-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 7(Granted Patents)

Company Filing History:

Years Active: 1996-2026

Loading Chart...

Areas of Expertise:

Sustained Release

Semaglutide

Levodopa

Dyskinesia

MUC1 Antibody

Ultrasonic Atomizer

Vitamin C Derivatives

HIV Protease Inhibitors

Pharmaceutical Composition

Aseptic Process

Anti-AIDS Activity

Peptide Composition

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734219 - SUSTAINED RELEASE FORMULATION COMPOSITION COMPRISING SEMAGLUTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF (2026-09-15),

2. 12622947 - Pharmaceutical composition for treating levodopa-induced dyskinesia or for suppressing progression thereof (2026-05-12),

3. 11739159 - Antibody binding specifically to MUC1 and use thereof (2023-08-29),

4. 11739158 - Antibody binding specifically to MUC1 and use thereof (2023-08-29),

5. 11718684 - Antibody binding specifically to MUC1 and use thereof (2023-08-08),

6. 11472887 - Antibody binding specifically to MUC1 and use thereof (2022-10-18),

7. 9776201 - Ultrasonic atomizer for aseptic process (2017-10-03),

8. 9757757 - Ultrasonic atomizer for aseptic process (2017-09-12),

9. 7521477 - Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same (2009-04-21),

10. 5773468 - Irreversible HIV protease inhibitor having an anti-aids activity and (1998-06-30),

11. 5763631 - Irreversible HIV protease inhibitors, intermediates, compositions and (1998-06-09),

12. 5744621 - Irreversible HIV protease inhibitors, intermediates, compositions and (1998-04-28),

13. 5696134 - Irreversible HIV protease inhibitors, intermediates, compositions and (1997-12-09),

14. 5587388 - Irreversible HIV protease inhibitors, intermediates, compositions and (1996-12-24),

Title: The Innovative Journey of Inventor Ho Il Choi

Introduction: Ho Il Choi is a distinguished inventor hailing from Daejeon, South Korea, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ho Il Choi holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his continuous commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Ho Il Choi has worked with leading tech companies and research institutions, playing a pivotal role in developing cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Ho Il Choi has collaborated with top engineers, scientists, and researchers globally, fostering a culture of innovation and knowledge exchange that has led to the creation of impactful inventions.

Conclusion: Ho Il Choi's passion for innovation, coupled with his relentless drive to solve complex challenges, has solidified his reputation as a visionary inventor in the tech world, inspiring the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.